LYM-1,HST_Biology of Indolent Lymphoma/CLL and Clinical Decision-Making(4-2)

日期:107年9月15日(六)14:00:00

時間:2018-09-15的14:00至17:40

類型:甲類

積分:3

主辦單位:LYM-1,HST

會議地點:南區-H2O水京棧國際酒店(2樓宴會AB廳)

交通指南:自行前往

節目表:
中華民國血液病學會 Lymphoma working group education program 2018 (4-2)
Biology of Indolent Lymphoma/CLL and Clinical Decision-Making
Date: 2018/09/15
Venue: 高雄H2O水京棧國際酒店2樓宴會AB廳 (高雄市鼓山區明華路366號 07- 5537001)
Chairman: 陳彩雲 醫師、王銘崇 醫師
Time Program Speaker
14:00 ~ 14:30 Registration
14:30 ~ 15:15
  • Marginal zone lymphoma, nodal and splenic: Differentiation among pathologically challenging entities
    • The role of IGHV repertoire
    • Mutational profiles in the NOTCH and BcR/TLR/NF-kB pathways
成大病理科/張孔昭教授
Discussion
15:15 ~ 16:00
  • Optimizing therapy of CLL based on clinical and biological factors
    • Frontline therapy
    • Behind frontline therapy
台大血液科/吳尚儒醫師
Discussion
16:00 ~ 16:10 Break time
16:10 ~ 16:55
  • Biology and management of lymphoplasmacytic lymphoma (and Waldenström macroglobulinemia)
    • Recent advances on the biology of LPL (and WM)
    • Available agents for the treatment of patients with LPL (and WM)
台大血液科/侯信安醫師
Discussion
16:55 ~ 17:40
  • Follicular lymphoma: are we ready for a risk-adapted approach?
    • The most appropriate application of the various clinical risk stratification tools available in follicular lymphoma
    • The limitations regarding current biologic risk stratification tools
台大血液科/柯博升醫師
Discussion
會後備有餐盒